Filing Flows › Bioventus (BVS) › How it makes money
How Bioventus (BVS) makes money
Bioventus (BVS) made $142M of revenue in the third quarter 2026 (Q3 2026), +3% from a year earlier. Of every dollar of revenue, 68¢ was left as gross profit, 7¢ was left as operating profit, 4¢ was left as net earnings.
Drawing the Sankey…
Where each dollar of revenue goes
| Line | Q3 2026 | % of revenue |
|---|---|---|
| Revenue | $142M | 100.0% |
| Cost of revenue | $45.3M | 31.8% |
| Gross profit | $97.1M | 68.2% |
| Operating expenses | $87.4M | 61.4% |
| Operating profit | $9.7M | 6.8% |
| Net earnings | $6.0M | 4.2% |
| Operating cash flow | $20.7M | 14.5% |
| Free cash flow | $20.3M | 14.3% |
Revenue, quarter by quarter
| Quarter | Revenue | Y/Y |
|---|---|---|
| Q3 2026 | $142M | +3% |
| Q2 2026 | $153M | +4% |
| Q1 2026 | $132M | +7% |
| Q4 2025 | $158M | +3% |
| Q3 2025 | $139M | -0.2% |
| Q2 2025 | $148M | -2% |
| Q1 2025 | $124M | -4% |
From Bioventus' 10-Q filed Nov 2, 2026 (on EDGAR).
Questions
How does Bioventus make money?
Bioventus (BVS) made $142M of revenue in the third quarter 2026 (Q3 2026), +3% from a year earlier. Of every dollar of revenue, 68¢ was left as gross profit, 7¢ was left as operating profit, 4¢ was left as net earnings.
What is Bioventus' profit margin?
Net earnings were $6.0M, 4.2% of revenue, in the third quarter 2026; the operating margin was 6.8%.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.